Programme

Programme Highlights

Endocrinology (31. 10. 2024)

Chair: Michal Kršek (Prague, Czechia)

Jens Bollerslev (Oslo, Norway) - Primary hyperparathyroidism
Martin Reincke (Munich, Germany) - Should all patients with hypertension be screened for primary aldosteronism? New answers to an old question.
Michal Kršek (Prague, Czechia) - Management of adrenal incidentaloma-an update

R3i

Chair: Jean-Charles Fruchart (Lille, France)

Michel Hermans (Brussels, Belgium) - What does it mean „Residual Risk“
Alberto Zambon (Padova, Italy) - How to manage atherogenic/diabetic DLP

Multimorbitidy

Chair: Jan Václavík (Ostrava, Czechia)

Emma Gans (Groningen, Netherlands) - A Tailored Approach to Care for Patients with Multiple Long-Term Conditions – insights from international guidelines
Máximo Bernabeu-Wittel (Sevilla, Spain) - Innovative strategies in managing drugs and polypharmacy in patients with multimorbidity.
Jan Václavík (Ostrava, Czechia) - Case based learning: How to rationalize pharmacotherapy of a multimorbid senior inpatient?

Gastroenterology

Chair: Milan Lukáš (Czechia)

Peter Malfertheine (Germany) - Efficacy and safety of proton pump inhibitors in clinical practice
Antonio Gasbarrini (Italy) - A role of microbiome based therapies in the gastrointestinal disorders
Milan Lukáš (Czechia) - Innovative therapy in IBD: focus on biologicals and small molecules